Your browser doesn't support javascript.
loading
DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
Verna, Elizabeth C; Morelli, Giuseppe; Terrault, Norah A; Lok, Anna S; Lim, Joseph K; Di Bisceglie, Adrian M; Zeuzem, Stefan; Landis, Charles S; Kwo, Paul; Hassan, Mohamed; Manns, Michael P; Vainorius, Monika; Akushevich, Lucy; Nelson, David R; Fried, Michael W; Reddy, K Rajender.
Afiliação
  • Verna EC; Columbia University, New York, NY.
  • Morelli G; Division of Gastroenterology, Hepatology, and Nutrition, University of Florida, Gainesville, FL.
  • Terrault NA; University of Southern California, Los Angeles, CA.
  • Lok AS; Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, MI.
  • Lim JK; Viral Hepatitis Program, Yale University School of Medicine, New Haven, CT.
  • Di Bisceglie AM; Chief of Hepatology, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Saint Louis University School of Medicine, Saint Louis, MO.
  • Zeuzem S; Department of Medicine, Goethe University Hospital, Frankfurt, Germany.
  • Landis CS; Department of Gastroenterology, University of Washington, Seattle, WA.
  • Kwo P; Department of Hepatology, Stanford University, Stanford, CA.
  • Hassan M; Division of Gastroenterology Hepatology and Nutrition, University of Minnesota, Minneapolis, MN.
  • Manns MP; Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany.
  • Vainorius M; Biometrics and Data Quality HCV-TARGET Data Coordinating Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Akushevich L; University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Nelson DR; Department of Medicine, University of Florida, Gainesville, FL.
  • Fried MW; Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC.
  • Reddy KR; Professor, Division of Gastroenterology and Hepatology, University of Pennsylvania, Philadelphia, PA. Electronic address: ReddyR@pennmedicine.upenn.edu.
J Hepatol ; 73(3): 540-548, 2020 09.
Article em En | MEDLINE | ID: mdl-32243960

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Índice de Gravidade de Doença / Hepacivirus / Hepatite C Crônica / Doença Hepática Terminal / Cirrose Hepática Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Antivirais / Índice de Gravidade de Doença / Hepacivirus / Hepatite C Crônica / Doença Hepática Terminal / Cirrose Hepática Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: J Hepatol Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2020 Tipo de documento: Article